台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.8
  • 漲跌
    ▼0.2
  • 漲幅
    -0.33%
  • 成交量
    26
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-凱基-豐中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-豐中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/19169.7000.0069.301881.12%
2024/11/140.270.5000.0069.700.21020.19%
2024/11/13377.4000.0077.403973.06%
2024/11/12186.0000.0086.001901.11%
2024/10/11196.9000.0097.4011370.72%
2024/09/190.196.4000.0096.500.11390.04%
2024/09/1000.00197.8096.50-1139-0.71%
2024/09/0900.00497.6098.10-4137-2.91%
2024/08/2000.002105.75104.50-2133-1.50%
2024/08/192105.501107.50106.0011300.77%
2024/08/131104.0000.00101.5011090.92%
2024/07/1200.001101.00102.00-193-1.07%
2024/06/261100.5000.00100.5011370.73%
2024/05/14198.601101.00102.0001440.00%
2024/05/130.1107.0000.00107.000.11270.04%
2024/05/061119.0000.00119.0011180.84%
2024/05/0300.002118.50118.50-2117-1.70%
2024/04/112.1119.001119.50119.501.11011.05%
2024/04/1000.001124.50127.00-195-1.04%
2024/04/0900.001123.50124.00-177-1.30%
2024/04/0300.004123.00123.50-471-5.59%
2024/03/272121.5000.00122.002663.02%
2024/03/261123.0000.00123.001631.57%
2024/03/1800.001122.00124.00-151-1.95%
2024/03/141119.0000.00119.001432.31%
2024/03/132117.0000.00116.502395.09%
2024/01/221111.0000.00111.501293.34%
2023/12/291115.0000.00115.001244.01%
2023/12/271115.0000.00115.001244.10%
2023/07/101108.5000.00108.501392.51%
2023/04/1000.001120.00120.50-139-2.56%
2023/04/0600.001119.00120.00-137-2.69%
2023/03/071113.5000.00113.001342.89%
2023/03/0200.0010.1109.50110.00-10.136-27.95%
2023/02/221107.5000.00108.001362.75%
2023/02/2100.001109.00108.00-136-2.76%
2023/01/122105.7500.00106.002385.15%
2022/12/072100.2500.00100.502365.45%
2022/12/051102.5000.00101.501323.07%
2022/12/021100.5000.00100.501303.31%
2022/12/011100.0000.00100.001293.44%
2022/11/251199.9500.00100.00112543.37%
2022/05/2500.00398.0098.40-343-6.82%
2022/05/2400.00198.6098.10-144-2.26%
2022/05/1600.001100.5098.70-141-2.42%
2022/05/121109.0000.00109.001332.98%
2022/03/0800.001124.00123.00-122-4.43%
2022/02/1700.001124.00125.00-121-4.71%
2022/02/151125.0000.00124.501204.79%
2022/02/141127.0000.00127.001195.13%
2022/01/031125.5000.00125.501293.41%
2021/11/1800.001.1128.00128.50-1.130-3.63%
2021/11/1700.001129.00128.00-130-3.28%
2021/11/091124.5000.00124.501293.36%
2021/10/050.1139.5000.00139.500.1350.14%
2021/08/021155.5000.00155.001342.90%
2021/07/2600.001150.00150.50-134-2.91%
2021/07/1200.000.1154.00150.50-0.133-0.30%
2021/07/0700.000.1153.00152.50-0.135-0.28%
2021/06/1000.001.1149.10151.50-1.146-2.39%
2021/06/0900.001147.00147.00-144-2.23%
2021/04/290.1148.0000.00147.500.1380.26%
2021/04/280.1147.0000.00146.500.1370.26%
2021/04/2600.001.5145.79146.00-1.537-3.95%
2021/04/2200.000.3146.50146.50-0.337-0.84%
2021/04/2000.000.2148.00147.50-0.237-0.49%
2021/04/133149.000.1150.00149.002.9377.73%
2021/04/120.1148.5000.00150.500.1360.28%
2021/04/0600.000.2138.50138.00-0.231-0.63%
2021/03/291143.0000.00143.501283.49%
2021/03/220.1138.0000.00140.500.1250.39%
2021/03/180.1134.5000.00135.000.1250.21%
2021/03/150.2134.3200.00133.000.2260.58%
2020/08/0600.001105.50105.50-158-1.71%
2020/08/0500.0012105.54106.00-1261-19.54%
2020/08/0400.0014105.54106.00-1462-22.30%
2020/08/0300.004105.25105.50-463-6.31%
2020/06/2400.001115.50116.00-159-1.67%
2020/06/2300.001114.50115.00-157-1.75%
2020/05/200108.5000.00109.000520.02%
2020/05/191107.5000.00107.001511.95%
2020/05/061101.5000.00102.001422.37%
2020/04/3000.001102.00102.00-141-2.42%
2020/04/22199.1000.0099.601442.25%
2020/04/1600.001100.50100.00-143-2.33%
2020/03/24194.0000.0094.001392.56%
2020/02/2100.001100.50101.50-126-3.82%
2020/02/1400.001101.00101.00-126-3.82%
2020/02/1200.000.1101.00101.00-0.126-0.37%
2019/12/171102.0000.00102.001195.16%
2019/12/120.1101.0000.00102.000.1200.50%
2019/10/311101.5000.00101.501214.56%
2019/10/222102.0000.00102.002238.52%
2019/10/171101.5000.00101.501244.09%
2019/05/0800.000.3109.50109.50-0.341-0.73%
2019/04/2300.001109.50109.50-140-2.50%
2019/04/1600.001109.00109.50-137-2.70%
2018/11/0600.001106.00106.00-129-3.39%
2018/11/0200.000.3103.00103.50-0.329-1.02%
2018/09/071108.502106.50106.00-152-1.89%
2018/08/1000.002110.25110.00-261-3.23%
2018/07/2400.001126.00126.00-184-1.18%
2018/06/011124.0000.00124.0011210.82%
2018/05/241125.5000.00125.0011260.79%
2018/05/151126.5000.00126.0011280.78%
2018/05/112126.0000.00124.5021301.53%
2018/05/101130.0000.00128.5011270.79%
2018/05/091130.5000.00129.0011270.79%
2018/05/0700.001132.50131.50-1124-0.80%
2018/05/041130.001130.00128.5001170.00%
2018/05/0300.001129.50129.00-1116-0.86%
2018/04/271125.0000.00124.0011170.85%
2018/04/261121.5000.00121.0011200.83%
2018/04/2400.001124.00122.00-1139-0.72%
2018/03/211130.5000.00128.5011830.54%
2018/01/2400.001122.00124.00-1158-0.63%
2018/01/221123.0000.00122.5011520.66%
2018/01/1500.001117.00118.00-1114-0.87%
2018/01/101112.5000.00112.0011020.98%
2018/01/0400.001111.50112.00-198-1.02%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音